Clinical trial
Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)
NCT00160407 is registered in ClinicalTrials.gov with St. Louis University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)
- Lead sponsor
- St. Louis University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2003
- Completion date
- December 31, 2006
- Enrollment
- 50
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.